Do TNFA-308 G/A and il6-174 G/C gene polymorphisms modulate risk of gallbladder cancer in the north indian population?

Asian Pacific Journal of Cancer Prevention

Volumn 8, Issue 4, 2007, Pages 567-572

  Vishnoi, Monika ^a   Pandey, Sachchida Nand ^a   Choudhury, Gourdas ^a   Kumar, Ashok ^a   Raj Modi, Dinesh ^b   Mittal, Balraj ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^b D D U GORAKHPUR UNIVERSITY   (India)

Author keywords

Gallbladder carcinoma; Gallstones; Genetic susceptibility; Il6; Inflammation; Polymorphism; TNFA

Indexed keywords

IL6 PROTEIN, HUMAN; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CASE CONTROL STUDY; COMPARATIVE STUDY; FEMALE; GALLBLADDER TUMOR; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HUMAN; INDIA; MALE; MIDDLE AGED; PATHOLOGY; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

CASE-CONTROL STUDIES; FEMALE; GALLBLADDER NEOPLASMS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INDIA; INTERLEUKIN-6; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 58249093765     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Ansar AS, Penhale WJ, Talal N (1985). Sex hormones, immuneresponses, and autoimmune diseases. Mechanisms of sex hormone action. Am J Pathol, 121, 531-51.
2. Asschert JG, Vellenga E, Ruiters MH, et al (1999). Regulation of spontaneous and TNF/IFN-induced IL-6 expression in two human ovarian-carcinoma cell lines. Int J Cancer, 82, 244-9.
3. Azmy IA, Balasubramanian SP, Wilson AG, et al (2004). Role of tumour necrosis factor gene polymorphisms (-308 and-238) in breast cancer susceptibility and severity. Breast Cancer Res, 6, 395-400.
4. Bamba H, Ota S, Kato A, et al (1998). Nonsteroidal antiinflammatory drugs may delay the repair of gastric mucosa by suppressing prostaglandin-mediated increase of hepatocyte growth factor production. Biochem Biophys Res Commun, 245, 567-71.
5. Baskaran V, Vij U, Sahni P, et al (2005). Do the progesterone receptors have a role to play in gallbladder cancer? Intl J Gastrointest Cancer, 35, 61-8.
6. Belluco C, Olivieri F, Bonafe M, et al(2003). 174G/C polymorphism of interleukin-6 gene promoter affects interleukin 6 serum level in patients with colorectal cancer. Clin. Cancer Res, 9, 2173-6.
7. Bouman A, Heineman M J, Faas M M (2005). Sex hormones and the immune response in humans. Hum Reprod, 11, 411-23.
8. Bowcock AM, Kidd JR, Lathrop GM, et al (1988). The human "interferon-ß 2/hepatocyte stimulating factor/interleukin-6" gene: DNA polymorphism studies and localization to chromosome 7p21. Genomics, 3, 8-16.
9. Chen D, Hu L, Yi P, et al (2007). Hpylori are associated with chronic cholecystitis. World J Gastroenterol, 21, 1119-22.
10. Chianale J, del Pino G, Nervi F (1990). Increasing gall-bladder cancer mortality rate during the last decade in Chile, a highrisk area. Int J of Cancer, 46, 1131-3.
11. Cutolo M, Capellino S, Montagna P, et al (2005). Sex Hormone Modulation of Cell Growth and Apoptosis of the Human Monocytic/Macrophage Cell Line. Arthritis Res Ther, 7, 1124-32.
12. Diehl S, Rincon M (2002). The two faces of IL-6 on Th1/Th2 differentiation. Mol Immunol, 39, 53-6.
13. Diehl AK (1983). Gallstone size and the risk of gallbladder cancer. JAMA, 250, 2323-6.
14. Duell EJ, Casella DP, Burk RD, et al (2006). Inflammation, genetic polymorphisms in proinflammatory genes TNF-A, RANTES, and CCR5, and risk of pancreatic adeno carcinoma. Cancer Epidemiol Biomarkers Prev, 15, 726-31.
15. Dutta U, Garg P K, Kumar R, et al (2000). Typhoid carriers among patients with gallstones are at increased risk for carcinoma of the gallbladder. Am J Gastroenterol, 95, 784-7.
16. Govan VA, Constant D, Hoffman M (2006). The allelic distribution of-308 Tumor Necrosis Factor-alpha gene polymorphism in South African women with cervical cancer and control women. BMC Cancer, 26, 24.
17. Indian Council of Medical Research (ICMR) (1996). Annual report of population based cancer registries of the National Cancer Registry Programme 1993. New Delhi. ICMR Publication: 18.
18. Jones SA, Horiuchi S, Topley N, et al (2001). The soluble interleukin 6 receptor: mechanisms of production and implications in disease. FASEB J, 15, 43-58
19. Kelberman D, Fife M, Rockman MV, et al (2004). Analysis of common IL-6 promoter SNP variants and the AnTn tract in humans and primates and effects on plasma IL-6 levels following coronary artery bypass graft surgery. Biochim Biophys Acta, 2, 160-7
20. Kohaar I, Thakur N, Salhan S, et al (2007). TNFalpha-308G/A polymorphism as a risk factor for HPV associated Cervical Cancer in Indian population. Cell Oncol, 29, 249-56
21. Lazcano-Ponce EC, Miquel JF, Munoz N, et al(2001). Epidemiology and molecular pathology of gallbladder cancer. CA Cancer J Clin, 51, 349-64.
22. Lee YH, Rho YH, Choi SJ, et al (2006). Association of TNFalpha-308 G/A polymorphism with responsiveness to TNFalpha-blockers in rheumatoid arthritis: a meta-analysis Rheumatol Int, 27, 157-61.
23. Leong R W, Sung J J (2002). Helicobacter species and hepatobiliary diseases. Aliment. Pharmacol. Ther, 16, 1037-45.
24. Macarthur M, Georgina LH, El-Omar EM (2004). Inflammation and Cancer II. Role of chronic inflammation and cytokine gene polymorphisms in the pathogenesis of gastrointestinal malignancy. Am. J. Physiol. Gastrointest. Liver Physiol, 286, 515-20.
25. Marsh HP, Haldar NA, Bunce M, et al (2003). Polymorphisms in tumor necrosis factor (TNF) are associated with risk of bladder cancer and grade of tumor at presentation. Br J Cancer, 89, 1096-101.
26. Miller SA, Dykes DD, Polesky HF (1988). A salting procedure for extracting DNA from nucleated cells. Nucleic Acid Res, 16, 1215.
27. Misra S, Chaturvedi A, Misra NC, et al (2003). Carcinoma of the gallbladder. Lancet Oncol, 4, 167-76.
28. Nakamura S, Muro H, Suzuki S (1989). Estrogen and progesterone receptors in gallbladder cancer. Jpn J Surg, 19, 189-94.
29. Nath G, Singh H, Shukla V K (1997). Chronic typhoid carriage and carcinoma of the gallbladder. Eur J Cancer Prev, 6, 557-9.
30. Nonomura N, Tokizane T, Nakayama M, et al (2006). Possible correlation between polymorphism in the tumor necrosis factor-beta gene and the clinicopathological features of bladder cancer in Japanese patients. Int J Urol, 13, 971-6.
31. Pandey SN, Modi DR, Choudhuri G, et al (2007). Slow acetylator genotype of N-acetyl transferase 2 (NAT2) is associated with increased susceptibility to gallbladder cancer: the cancer risk not modulated by gallstone disease. Cancer Biol Ther, 6, 97-8.
32. Randi G, Franceschi S, La Vecchia C (2006). Gallbladder cancer worldwide: geographical distribution and risk factors. Int J Cancer, 118, 1591-602.
33. Robert VR (2000). Inflammatory cytokines alter human gallbladder epithelial cell absorption/secretion. J Gastrointest Surg, 4, 185-92.
34. Shih CM, Lee YL, Chiou HL, et al (2006). Association of TNFalpha polymorphism with susceptibility to and severity of non-small cell lung cancer. Lung Cancer, 52, 15-20.
35. Sykora J, Subrt I, Didek P, et al (2006). Cytokine Tumor Necrosis Factor-alpha A Promoter Gene Polymorphism at Position-308 G>A and Pediatric Inflammatory Bowel Disease: Implications in Ulcerative Colitis and Crohn's Disease. J Pediatr Gastroenterol Nutr, 42, 479-87.
36. Vickers MA, Green FR, Terry C, et al (2002). Genotype at a promoter polymorphism of the interleukin-6 gene is associated with baseline levels of plasma C-reactive protein. Cardiovasc Res, 53, 1029-34.
37. Wehbe H, Henson R, Meng F, et al (2006). Interleukin-6 contributes to growth in cholangiocarcinoma cells by aberrant promoter methylation and gene expression. Cancer Res, 66, 10517-24
38. Wilson A G, di Giovine F S, Blakemore AIF, et al (1992). Single base polymorphism in the human tumour necrosis factor alpha (TNF alpha) gene detectable by NcoI restriction of PCR product. Hum Mol Genet, 1, 353
39. Wistuba II, Gazdar AF (2004). Gallbladder cancer: Lessons from a rare tumor. Nat rev Cancer, 4, 695-706.
40. Ye S, Dhillon S, Ke X, et al (2001). An efficient procedure for genotyping single nucleotide polymorphisms. Nucleic Acid Res, 29, 88-8.